MUC4 mucin potentiates pancreatic tumor cell proliferation, survival, and invasive properties and interferes with its interaction to extracellular matrix proteins.
about
MicroRNA-150 directly targets MUC4 and suppresses growth and malignant behavior of pancreatic cancer cellsMembrane-bound mucins: the mechanistic basis for alterations in the growth and survival of cancer cellsGraviola: a novel promising natural-derived drug that inhibits tumorigenicity and metastasis of pancreatic cancer cells in vitro and in vivo through altering cell metabolismMUC4 mucin interacts with and stabilizes the HER2 oncoprotein in human pancreatic cancer cellsStructure, evolution, and biology of the MUC4 mucinMucins in cancer: function, prognosis and therapyThe membrane mucin MUC4 is elevated in breast tumor lymph node metastases relative to matched primary tumors and confers aggressive properties to breast cancer cellsFunctional Consequences of Differential O-glycosylation of MUC1, MUC4, and MUC16 (Downstream Effects on Signaling)Gastrointestinal effects of Nigella sativa and its main constituent, thymoquinone: a reviewMucin-based targeted pancreatic cancer therapyMucins in neoplasms of pancreas, ampulla of Vater and biliary systemAltered expression of transmembrane mucins, MUC1 and MUC4, in bladder cancer: pathological implications in diagnosis.Mucins: a new family of epigenetic biomarkers in epithelial cancers.Establishment and characterization of a new human pancreatic adenocarcinoma cell line with high metastatic potential to the lung.Recent progress on normal and malignant pancreatic stem/progenitor cell research: therapeutic implications for the treatment of type 1 or 2 diabetes mellitus and aggressive pancreatic cancer.Tenectin is a novel alphaPS2betaPS integrin ligand required for wing morphogenesis and male genital looping in DrosophilaOncogenic Kras activates a hematopoietic-to-epithelial IL-17 signaling axis in preinvasive pancreatic neoplasia.TET1-mediated DNA hypomethylation regulates the expression of MUC4 in lung cancer.MUC13 mucin augments pancreatic tumorigenesis.MUC4 down-regulation reverses chemoresistance of pancreatic cancer stem/progenitor cells and their progeniesEffects of thymoquinone in the expression of mucin 4 in pancreatic cancer cells: implications for the development of novel cancer therapiesPrognostic value of mucin 4 expression in colorectal adenocarcinomas.Human intestinal MUC17 mucin augments intestinal cell restitution and enhances healing of experimental colitisAberrant upregulation of MUC4 mucin expression in cutaneous condyloma acuminatum and squamous cell carcinoma suggests a potential role in the diagnosis and therapy of skin diseases.Pathobiological implications of MUC16 expression in pancreatic cancer.Google goes cancer: improving outcome prediction for cancer patients by network-based ranking of marker genes.Nucleotide variability and linkage disequilibrium patterns in the porcine MUC4 gene.MUC4 regulates cellular senescence in head and neck squamous cell carcinoma through p16/Rb pathway.Evidence for the importance of personalized molecular profiling in pancreatic cancer.MUC4 mucin-induced epithelial to mesenchymal transition: a novel mechanism for metastasis of human ovarian cancer cells.The molecular targets for the diagnosis and treatment of pancreatic cancer.Novel INTeraction of MUC4 and galectin: potential pathobiological implications for metastasis in lethal pancreatic cancer.Specific-detection of clinical samples, systematic functional investigations, and transcriptome analysis reveals that splice variant MUC4/Y contributes to the malignant progression of pancreatic cancer by triggering malignancy-related positive feedbMUC4 overexpression augments cell migration and metastasis through EGFR family proteins in triple negative breast cancer cells.Activated KrasG¹²D is associated with invasion and metastasis of pancreatic cancer cells through inhibition of E-cadherin.MicroRNA-200c modulates the expression of MUC4 and MUC16 by directly targeting their coding sequences in human pancreatic cancer.Role of mucins in the skin during benign and malignant conditions.Targeting EGF-receptor(s) - STAT1 axis attenuates tumor growth and metastasis through downregulation of MUC4 mucin in human pancreatic cancerRole of microRNA-150 in solid tumors.Role of MUC4-NIDO domain in the MUC4-mediated metastasis of pancreatic cancer cells
P2860
Q24596316-23BE5B93-2774-43A1-B00A-1EA63D998318Q24601584-FCD6D714-DBA3-4C47-9014-FA293A73D12CQ24608066-F31B6814-8E86-4E69-AE51-775B9F5147BAQ24630950-373350CC-D3A7-45EE-96D5-4AB792050F5CQ24630985-10B6555F-66CF-4FEF-9007-11F62401216FQ24633765-C43616BD-BF67-44DA-9398-6AE4596873A9Q24644445-AF4A0F81-F75C-44B7-B3F6-581733E74100Q26739942-EF1C0006-D9AF-43E0-BB66-4EE8781BDF91Q26744253-933F4358-1AD0-4FF3-81AA-EE81E0B06905Q26861761-0A2C3D1F-3939-4D37-8D2D-806DC353822DQ28070355-1B5BE55C-887F-4976-86E0-0A730C81A8B0Q30414136-F2E4949A-65B3-45C0-AAAE-585EB6248F08Q30597703-F6B50AE3-10E1-4F00-8A29-D03FF316E396Q33606248-FB2E0AA0-2B78-4EB4-A6D9-5800D974BEA9Q33719099-6D555197-3B03-41F2-BCCE-5CB2EABF0EE4Q33787816-A294D4A0-7C5B-4C73-A69D-E967ACA5DAAAQ33810570-5EA47F35-6A17-4651-879A-6AC74655DB01Q33849697-0D42C4A2-6F6D-420D-960D-1540B677F2F1Q33909073-3D35140C-CAFC-4536-B1CC-2146F6750EB8Q33938044-4B098D34-2E24-4C38-988E-DD0A2E5A8D99Q34003722-BD522E0A-CCB6-4EA0-9C18-BB318C8DBCE3Q34023248-33B61A9E-B1B5-4E9B-B12A-791A10F5A5B4Q34056835-7053020F-DBAC-4A57-A2DA-05F1D03BB21EQ34060189-63A42440-E41F-4884-82B9-5CD0C7808F1FQ34069612-47A1F302-CF3B-4719-96A4-2798047819A0Q34276961-7C26ED7C-4977-43E3-86B6-FD5CD0151CC8Q34336892-BF36C5AC-38AA-4570-8235-6828331A5810Q34381590-C259B84C-154A-4B98-A208-7D0CBD8C4B53Q34387784-4C990C82-BD1A-4CE3-A284-DC705BA93D41Q34423709-7CCEDE11-76FF-41B5-B2EB-43037A2C7E20Q34494019-7FD5F82C-E0E1-4DD8-8A60-6C8A843439D7Q34500864-75848713-D9C1-42B6-A652-E7D1C77D0DF0Q34537320-0E3C1548-7D75-4836-80AF-16EF34ED1AECQ34585874-1542D314-048F-4398-B276-C615427C7A01Q34727214-A0FF777E-C86E-40F2-B98A-209EFD6D05B1Q35034437-458873E6-3E5D-4499-A8A3-3BE4E3887FE6Q35596376-0836B30D-029B-4888-B5D9-4767B4E675F5Q35741633-5515599C-E30B-4139-908A-739AD8F1E4A7Q35803040-2019A7EA-86E3-4E96-AE38-DCE3C70B7ACBQ35818749-20DEEE22-8E34-4C4D-8D06-9F1993FFF3B6
P2860
MUC4 mucin potentiates pancreatic tumor cell proliferation, survival, and invasive properties and interferes with its interaction to extracellular matrix proteins.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
MUC4 mucin potentiates pancrea ...... extracellular matrix proteins.
@en
type
label
MUC4 mucin potentiates pancrea ...... extracellular matrix proteins.
@en
prefLabel
MUC4 mucin potentiates pancrea ...... extracellular matrix proteins.
@en
P2093
P50
P1476
MUC4 mucin potentiates pancrea ...... extracellular matrix proteins
@en
P2093
Jane L Meza
Pallavi Chaturvedi
Subhankar Chakraborty
Surinder K Batra
P304
P356
10.1158/1541-7786.MCR-06-0353
P577
2007-04-03T00:00:00Z